Question 1

What does the tender “Screen The A10 Antibody For Off-Target Binding To Plasma Membrane Proteins And Secreted Proteins” cover and in which sector is it issued?

Accepted Answer

The tender “Screen The A10 Antibody For Off-Target Binding To Plasma Membrane Proteins And Secreted Proteins” is a tender record in Taiyo, linked to the Residential sector. It is issued for works, goods, or services related to Saffron, GB-ESS, Scotland.

Question 2

What is the current bidding status of the tender “Screen The A10 Antibody For Off-Target Binding To Plasma Membrane Proteins And Secreted Proteins”?

Accepted Answer

The status recorded for “Screen The A10 Antibody For Off-Target Binding To Plasma Membrane Proteins And Secreted Proteins” is award notice.

Question 3

What is the procurement method and commercial structure for “Screen The A10 Antibody For Off-Target Binding To Plasma Membrane Proteins And Secreted Proteins”?

Accepted Answer

The budget is USD 38750.

Question 4

How can I verify the tender source and access bidding documents for “Screen The A10 Antibody For Off-Target Binding To Plasma Membrane Proteins And Secreted Proteins”?

Accepted Answer

Taiyo’s tender pages link back to the originating system via https://sam.gov/workspace/contract/opp/1f593f2d0a2a4dc6b1e87d1efe846498/view, referencing SAM.gov as the source. Users can follow the official link to download tender documents and submission instructions.

Original status	award notice
Taiyo status	Closed
Taiyo last update	2026-11-03

Description	This is a Firm Fixed Priced purchase order. NCI solicited and negotiated directly with Charles River Discovery Research Services UK Limited. The National Cancer Institute (NCI) has a program to use an antibody called, 'A10' to target cancer cells that have a lot of the epidermal growth factor receptor on their cell surface. While this antibody has been extensively tested and characterized it is not known if it also binds any other cell surface proteins. The contractor shall perform an off-target screen on an NCI antibody and report back on any problematic interactions that could predict a serious side effect should the antibody be given to a cancer patient. The A10 is NOT known to bind other cell surface proteins or secreted proteins but this needs to be addressed in the off-target screen.
Original sector	Professional, Scientific, and Technical Services
Budget

Country	United Kingdom (UK)
State	GB-ESS
City	Saffron

Record type	Tender
Sector	Residential, Commercial
Article published date	2026-02-07

Screen The A10 Antibody For Off-Target Binding To Plasma Membrane Proteins And Secreted Proteins

Ask ConstructChat about Screen The A10 Antibody For Off-Target Binding To Plasma Membrane Proteins And Secreted Proteins

Tender Information

Research

View all details

Source	SAM.gov
URL

Screen The A10 Antibody For Off-Target Binding To Plasma Membrane Proteins And Secreted Proteins

Ask ConstructChat about Screen The A10 Antibody For Off-Target Binding To Plasma Membrane Proteins And Secreted Proteins

Tender Information FAQ

Tender Information

Research

View all details

More Residential tenders in Scotland